Vulnerability in Biotronik Cardiomessenger Ii-S Gsm
CVE-2019-18254
BIOTRONIK CardioMessenger II, The affected products do not encrypt sensitive information while at rest. An attacker with physical access to the CardioMessenger can disclose medical measurement data and the serial number from the implanted cardiac device the CardioMessenger is paired with.
EPSS: 0.002 (13.4th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 4.6 (Medium). Vector: CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.
Affected products
- Biotronik Cardiomessenger_ii-s_gsm
- Biotronik Cardiomessenger_ii-s_gsm_firmware — versions 2.20
- Biotronik Cardiomessenger_ii-s_t-line
- Biotronik Cardiomessenger_ii-s_t-line_firmware — versions 2.20
- N/a Biotronik Cardiomessenger Ii-s T-line, Gsm — versions CardioMessenger II-S T-Line T4APP 2.20, CardioMessenger II-S GSM T4APP 2.20
Weakness classification (CWE)
References
- ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC)
Frequently asked questions
- What is CVE-2019-18254?
- CVE-2019-18254 is a medium-severity vulnerability in Biotronik Cardiomessenger Ii-S Gsm, classified under Missing Encryption of Sensitive Data. CVSS score: 4.6/10. Published 2020-06-29.
- How severe is CVE-2019-18254?
- Medium severity. CVSS v3 base score is 4.6 out of 10.